Global Insulin Syringes Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Insulin Syringes Market Research Report 2024
An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.
According to Mr Accuracy reports new survey, global Insulin Syringes market is projected to reach US$ 2151.9 million in 2029, increasing from US$ 1612 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Insulin Syringes market research.
The Insulin Syringes market is expected to be positively impacted by the COVID-19 pandemic. As patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administrated with syringes or pens) and care.Thus, the adoption of insulin syringes and continuous glucose monitoring devices has increased for close monitoring and optimal management of diabetes. The major factor that contributes to the growth of the insulin syringes market include surge in aging population and increased number of diabetic patients globally. Furthermore, other factors such as favorable government policies related to insulin syringes are the key factors that drive the growth of the market. In addition, surge in incidence of obesity and people adopting an unhealthy lifestyle supplement the growth of market. Moreover, rise in prevalence of various chronic diseases such as type-1 and type-2 diabetes, is another major factor that boosts the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Syringes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
Terumo Corporation
Cardinal Health Inc
Medline Industries
Braun Melunsun
Nipro Medical Corporation
HMD Healthcare Ltd
Segment by Type
3/10 CC Syringe
1/2 CC Syringe
1 CC Syringe
Others
Hospital
Homecare
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Insulin Syringes report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Insulin Syringes market is projected to reach US$ 2151.9 million in 2029, increasing from US$ 1612 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Insulin Syringes market research.
The Insulin Syringes market is expected to be positively impacted by the COVID-19 pandemic. As patients with different health issues such as, diabetes and high blood pressure are at higher risk of getting affected by virus. It is found that the mortality rate is high in a patient with diabetes compared to the general population. The people having diabetes require continuous access to insulin (administrated with syringes or pens) and care.Thus, the adoption of insulin syringes and continuous glucose monitoring devices has increased for close monitoring and optimal management of diabetes. The major factor that contributes to the growth of the insulin syringes market include surge in aging population and increased number of diabetic patients globally. Furthermore, other factors such as favorable government policies related to insulin syringes are the key factors that drive the growth of the market. In addition, surge in incidence of obesity and people adopting an unhealthy lifestyle supplement the growth of market. Moreover, rise in prevalence of various chronic diseases such as type-1 and type-2 diabetes, is another major factor that boosts the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Syringes market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
Terumo Corporation
Cardinal Health Inc
Medline Industries
Braun Melunsun
Nipro Medical Corporation
HMD Healthcare Ltd
Segment by Type
3/10 CC Syringe
1/2 CC Syringe
1 CC Syringe
Others
Segment by Application
Hospital
Homecare
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Insulin Syringes report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source